With reference to the communication dated May 14, 2021, seeking clarification for movement in price, Gufic Biosciences has clarified that there is no pending information or announcement (including impending announcement) from the Company which in its opinion may have a bearing on the price / volume behaviour in the scrip. The movement in the shares price of the Company is purely due to market conditions and absolutely market driven and the Management of the Company is no way connected with any such price increase/volume increase.
The above information is a part of company’s filings submitted to BSE.
